Patent · US Active

Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same

US7981905B2 · kind B2 · utility

14Cited by

1References

36Claims

0Family size

Assignee

OPKO Health, Inc. · US

Inventors

Zhihui Qiu · Bound Brook, US
Larisa Reyderman · Watchung, US

Key dates

Filing date	Jun 18, 2009
Grant date	Jul 19, 2011
Priority date	—
Expiry date	Jun 18, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical formulations containing salts of (5S,8S)-8-[{(1R)-1-(3,5-Bis-(trifluoromethyl)phenyl]-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I, are disclosed. Disclosed also are methods of treatment utilizing such dosage forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.